Home | My NASDAQ | Tools | Mobile | Company List | ETFs | Pre-Market Quotes Real-Time Quotes After Hours Quotes
Home > Quotes > MYL > Company News
MYL
MYL
$21.63
*
0.35
negative
1.64%

*Data as of May 25, 2012   | Mylan Inc. | Industry: Consumer Durables | HQ: Pennsylvania, United States
 
 

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 |  Sponsored

MYL News Headlines

Share |


   


Markets Close Lower Today on EU Worries But Stocks Snap 3-Week Losing Streak
5/25/2012 4:31:00 PM - Knobias

Mylan Launches Bonviva Generic - Analyst Blog
5/25/2012 1:45:01 PM - Zacks.com

Stocks Remain Weaker at Midday on EU Crisis
5/25/2012 1:26:00 PM - Knobias

Stocks Flat-to-Mixed in Early Trading Despite Positive Consumer Sentiment Report for May
5/25/2012 10:29:00 AM - Knobias

Futures Indicating Lower Open for Markets on EU Concerns
5/25/2012 9:12:00 AM - Knobias

Stock Futures Point to Flat Session Ahead of Long Holiday Weekend
5/25/2012 8:16:00 AM - Knobias

More Generic Launches for Mylan - Analyst Blog
5/24/2012 5:46:40 PM - Zacks.com

Mylan Reaches Deal To Resolve Patent Litigation On Sunovion's Brovana Product
5/24/2012 5:46:00 PM - RTT News

Mylan Launches Generic Version Of Bonviva Film Coated Tablets In The UK, Italy
5/24/2012 1:31:00 PM - RTT News

Shire Presents Data on Venvanse - Analyst Blog
5/24/2012 12:43:56 PM - Zacks.com

WCRX, Watson Pharma in Legal Tussle - Analyst Blog
5/23/2012 3:43:59 PM - Zacks.com

Mylan Receives FDA Approval For Generic Version Of Viramune Tablets
5/23/2012 12:00:00 PM - RTT News

The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr. Reddy's Laboratories - Press Releases
5/22/2012 9:30:01 AM - Zacks.com

Generic Launches Continue at Mylan - Analyst Blog
5/21/2012 1:15:01 PM - Zacks.com

FDA Approves Generic Versions Of Clot-buster Plavix
5/18/2012 12:04:00 AM - RTT News

UPDATE:FDA Approves Generic Versions Of Blood-Thinning Drug Plavix
5/17/2012 3:39:00 PM - Dow Jones Business News

FDA Approves Generic Versions Of Blood Thinning Drug Plavix
5/17/2012 3:02:00 PM - Dow Jones Business News

Mylan Receives FDA Approval For Generic Version Of Plavix Tablets - Quick Facts
5/17/2012 2:04:00 PM - RTT News

Mylan Raises 2012 Earnings Guidance - Analyst Blog
5/11/2012 5:06:50 PM - Zacks.com

Stocks Close Mixed and Post Second Consecutive Weekly Decline
5/11/2012 4:26:00 PM - Knobias

Stocks Modestly Higher at Midday on Positive Data
5/11/2012 1:32:00 PM - Knobias

Stocks Turn Mixed After Jump in May Consumer Sentiment
5/11/2012 10:34:00 AM - Knobias

Markets Headed for Lower Open After JP Morgan Reveals $2 Billion in Trading Losses
5/11/2012 9:19:00 AM - Knobias

Mylan Launches Atorvastatin Calcium Tablets In Five European Countries
5/11/2012 7:36:00 AM - RTT News

Markets Open Higher and Extend Gains in Early Trading
5/10/2012 10:30:00 AM - Knobias